<a href="https://laohu8.com/S/CDIXD">Cardiff Lexington</a> Corp. Reports 89.5% Revenue Increase and 482.3% Rise in Income for <a href="https://laohu8.com/S/QTWO">Q2</a> 2025
Cardiff Lexington Corporation has announced its financial results for the second quarter ended June 30, 2025. The company reported a significant 89.5% increase in total revenue, reaching $2.8 million compared to the same period in 2024. Gross profit surged by 149.8% to $1.7 million, while income from continuing operations saw a dramatic rise of 482.3% to $610,000 compared to the second quarter of 2024. In terms of financial health, Cardiff Lexington's non-GAAP adjusted EBITDA, excluding interest expense, increased by 181.1% to $1.3 million, up from $446,000 in the first six months of 2024. The company's cash position was $560,000 as of June 30, 2025, with total assets climbing 10.8% to $26.5 million. Total stockholders' equity stood at $754,000. The company is experiencing strong demand, particularly at its 12 Nova Ortho & Spine locations in Florida and Georgia. Cardiff Lexington is focusing on expanding its footprint through organic growth and strategic mergers and acquisitions, as well as increasing operating capacity to drive long-term growth and value for shareholders.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardiff Lexington Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1065238) on August 26, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.